68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
Abstract Background 68Ga-labelled prostate specific membrane antigen (PSMA) ligand PET/CT is a promising modality in primary staging (PS) and biochemical relapse (BCR) of prostate cancer (PC). However, pelvic nodes or local recurrences can be difficult to differentiate from radioactive urine. CT uro...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2017-12-01
|
| シリーズ: | Cancer Imaging |
| 主題: | |
| オンライン・アクセス: | http://link.springer.com/article/10.1186/s40644-017-0133-5 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
